These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 33610741)

  • 1. Coronavirus-induced autoimmunity.
    Salle V
    Clin Immunol; 2021 May; 226():108694. PubMed ID: 33610741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies.
    Ding Z; Wei X; Pan H; Shi H; Shi Y
    Scand J Immunol; 2024 Feb; 99(2):e13344. PubMed ID: 39007954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
    Vojdani A; Vojdani E; Kharrazian D
    Front Immunol; 2020; 11():617089. PubMed ID: 33584709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
    Mohkhedkar M; Venigalla SSK; Janakiraman V
    Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mimicry and autoimmunity in the time of COVID-19.
    Rojas M; Herrán M; Ramírez-Santana C; Leung PSC; Anaya JM; Ridgway WM; Gershwin ME
    J Autoimmun; 2023 Sep; 139():103070. PubMed ID: 37390745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune complications of COVID-19.
    Yazdanpanah N; Rezaei N
    J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of autoimmunity induced by SARS-CoV-2 and development of post-vaccination autoimmune diseases].
    Montaño-Armendáriz N; Zamudio-Cuevas Y; Fernández-Torres J; Martínez-Flores K; Luján-Juárez IA
    Rev Alerg Mex; 2023 Jan; 69(2):78-88. PubMed ID: 36928248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
    Vahabi M; Ghazanfari T; Sepehrnia S
    Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: adrenal response and molecular mimicry.
    Churilov LP; Kanduc D; Ryabkova VA
    Isr Med Assoc J; 2021 Oct; 23(10):618-619. PubMed ID: 34672441
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins.
    Nunez-Castilla J; Stebliankin V; Baral P; Balbin CA; Sobhan M; Cickovski T; Mondal AM; Narasimhan G; Chapagain P; Mathee K; Siltberg-Liberles J
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
    Karagöz IK; Munk MR; Kaya M; Rückert R; Yıldırım M; Karabaş L
    Exp Eye Res; 2021 Feb; 203():108433. PubMed ID: 33400927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
    Szekanecz Z; Balog A; Constantin T; Czirják L; Géher P; Kovács L; Kumánovics G; Nagy G; Rákóczi É; Szamosi S; Szűcs G; Vályi-Nagy I
    Expert Rev Mol Med; 2022 Mar; 24():e13. PubMed ID: 35311631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and COVID-19.
    Mares J; Hartung HP
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):217-225. PubMed ID: 32686774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Mechanisms Underpinning Long COVID: Collegium Internationale Allergologicum Update 2024.
    Untersmayr E; Venter C; Smith P; Rohrhofer J; Ndwandwe C; Schwarze J; Shannon E; Sokolowska M; Sadlier C; O'Mahony L
    Int Arch Allergy Immunol; 2024; 185(5):489-502. PubMed ID: 38253027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SARS-CoV-2 infection and autoimmunity].
    Meyer-Bahlburg A
    Z Rheumatol; 2024 Feb; 83(1):34-40. PubMed ID: 38108865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mimicry between SARS-CoV-2 and human proteins.
    Adiguzel Y
    Autoimmun Rev; 2021 Apr; 20(4):102791. PubMed ID: 33610750
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
    Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.